The Company will be initiating a clinical validation study on the use of its proprietary biomarker testing in Alzheimer’s Disease...

Focused on generating data through proprietary biomarkers and diagnostic testing of inflammation VANCOUVER, BC, Nov. 9, 2021 /CNW/ – MYND...

VANCOUVER, BC, Oct. 28, 2021 /PRNewswire/ – MYND Life Sciences Inc. (“MYND” or the “Company”) (CSE: MYND) (OTC: MYNDF) announces the...